Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI crossover study of naloxegol and codeine on gastrointestinal motility and volumes
2024-512673-28-00Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Sep 2024
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in opioid-induced constipation (OIC) comparing placebo + placebo, naloxegol + codeine and placebo + codeine (3 arms). Started Sep 2024; status: completed.
02
Drugs
naloxegolcodeine
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on 2024-512673-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512673-28-00.